VTRS Q3 2020 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

Q3 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$3.0B+0.4% YoY

Gross Profit

$1.2B39.0% margin

Operating Income

$351M11.8% margin

Net Income

$186M6.2% margin

EPS (Diluted)

$0.36

QoQ Revenue Growth

+8.8%

Cash Flow

Operating Cash Flow

$525M

Free Cash Flow

$487M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$31.2B

Total Liabilities

$18.7B

Stockholders' Equity

$12.5B

Cash & Equivalents

$665M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.0B	$3.0B	+0.4%
Gross Profit	$1.2B	$1.1B	+8.0%
Operating Income	$351M	$324M	+8.6%
Net Income	$186M	$190M	-2.2%